Caricamento...
Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease
AIM: The aim of the study was to assess ticagrelor's effects on inhibition of platelet aggregation (IPA), P2Y(12) reaction units (PRU, measure of platelet P2Y(12) receptor blockade), pharmacokinetic (PK) parameters and safety in Chinese patients with stable coronary artery disease (CAD). METHOD...
Salvato in:
| Pubblicato in: | Br J Clin Pharmacol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4972151/ https://ncbi.nlm.nih.gov/pubmed/27038001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12950 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|